FDA Approval Mifepristone REMS Program Modification Expands

The Food and Drug Administration (the “FDA”) has approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy (“REMS”) Program, increasing the accessibility of...

Related Keywords

Maryland , United States , American , , Jackson Women Health Organization , Drug Administration , Sheppard Mullin Richter Hampton , Maryland Us District Court , Us Supreme Court , American College Of Obstetricians , American Civil Liberties Union , Mitigation Strategy Program , Program Modifications , Program For Mifeprex , Sheppard Mullin Richter , Mifepristone Risk Evaluation , Mitigation Strategy , Mifepristone Tablets , American College , Health Organization , Prescriber Agreement Form , Pharmacy Agreement Form , Medication Guide , Patient Agreement Form , Medical Termination , Pregnancy Through Ten Weeks Gestation , Risk Evaluation , Mitigation Strategies , Approving Mifepristone ,